×
About 175,128 results

ALLMedicine™ Heart Failure Center

Research & Reviews  52,899 results

Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Ad...
https://doi.org/10.1161/CIRCHEARTFAILURE.121.009120
Circulation. Heart Failure; Bundgaard H, Axelsson Raja A et. al.

Jun 28th, 2022 - β3-AR (β3-adrenergic receptor) stimulation improved systolic function in a sheep model of systolic heart failure (heart failure with reduced ejection fraction [HFrEF]). Exploratory findings in patients with New York Heart Association functional cl...

Not All β-Receptors Appear the Same in Heart Failure: Emergence of β3-Agonists as a The...
https://doi.org/10.1161/CIRCHEARTFAILURE.122.009685
Circulation. Heart Failure; Roy R, Koch WJ

Jun 28th, 2022 - Not All β-Receptors Appear the Same in Heart Failure: Emergence of β3-Agonists as a Therapeutic Option.|2022|Roy R,Koch WJ,|

Oral iron supplementation in patients with heart failure: a systematic review and meta-...
https://doi.org/10.1002/ehf2.14020
ESC Heart Failure; Song Z, Tang M et. al.

Jun 28th, 2022 - This review aimed to assess whether oral iron supplementation in a chronic heart failure (HF) population with iron deficiency (ID) or mild anaemia is safe and effective according to evidence-based medicine. We retrieved 1803 records from the PubMe...

A circular RNA derived from the insulin receptor locus protects against doxorubicin-ind...
https://doi.org/10.1093/eurheartj/ehac337
European Heart Journal; Lu D, Chatterjee S et. al.

Jun 28th, 2022 - Cardiotoxicity leading to heart failure (HF) is a growing problem in many cancer survivors. As specific treatment strategies are not available, RNA discovery pipelines were employed and a new and powerful circular RNA (circRNA)-based therapy was d...

A survey-based triage tool to identify patients potentially eligible for referral to an...
https://doi.org/10.1002/ehf2.14024
ESC Heart Failure; Murphy L, Giblin GT et. al.

Jun 28th, 2022 - Accurate prevalence data for ambulatory advanced heart failure (HF) in European countries remains limited. This study was designed to identify the population of patients potentially eligible for referral for assessment for advanced surgical HF the...

see more →

Guidelines  91 results

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic ...
https://doi.org/10.1016/j.echo.2022.03.012
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...

Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis...
https://doi.org/10.1016/j.hrthm.2022.02.022
Heart Rhythm; Sandhu RK, Seiler A et. al.

Apr 17th, 2022 - An integrated, coordinated, and patient-centered approach to atrial fibrillation (AF) care delivery may improve outcomes and reduce cost. The purpose of this study was to gain a better understanding from key stakeholder groups on current practices...

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the Americ...
https://doi.org/10.1016/j.jacc.2021.12.012
Journal of the American College of Cardiology; Heidenreich PA, Bozkurt B et. al.

Apr 6th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart F...

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A R...
https://doi.org/10.1016/j.jacc.2021.12.011
Journal of the American College of Cardiology; Heidenreich PA, Bozkurt B et. al.

Apr 6th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart F...

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
https://doi.org/10.1016/j.cardfail.2022.02.010
Journal of Cardiac Failure; ,

Apr 5th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart F...

see more →

Drugs  2,241 results see all →

Clinicaltrials.gov  6,339 results

Screening for Advanced Heart Failure Treatment (SEE-HF)
https://clinicaltrials.gov/ct2/show/NCT01626404

Jun 24th, 2022 - Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who...

Nudge to Drive Transitions of Care
https://clinicaltrials.gov/ct2/show/NCT04660032

Jun 24th, 2022 - Background: Women with HDP need ongoing care in the postpartum and inter-pregnancy period. HDP, including preeclampsia (PEC) and gestational hypertension (GHTN), complicate up to 10% of all pregnancies and are associated with immediate and long-te...

Heart Failure Patients Registry
https://clinicaltrials.gov/ct2/show/NCT04709263

Jun 24th, 2022 - This study is a multicenter non-interventional observational prospective registry. This non-interventional study (NIS) does not imply any intervention into a routine clinical practice, including choice of treatment modality or special methods of i...

The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure
https://clinicaltrials.gov/ct2/show/NCT04688294

Jun 24th, 2022 - The aim of this study is to evaluate the bio-clinical effects of sacubitril/valsartan combination in treatment of patients with Congestive heart failure. Moreover, the investigators aim to evaluate side effects of this combination. - The following...

Hong Kong and Taiwan HM3 PMS
https://clinicaltrials.gov/ct2/show/NCT04703855

Jun 24th, 2022 - Hong Kong and Taiwan HM3 PMS is a prospective, single arm, post market surveillance is designed to evaluate clinical and functional outcomes with the HM3 LVAS as a treatment for advanced heart failure. The PMS will enroll approximately 30 patients...

see more →

News  8,383 results

ACC/AHA Issue Clinical Lexicon for Complications of COVID-19
https://www.medscape.com/viewarticle/976259

Jun 27th, 2022 - The American College of Cardiology (ACC) and the American Heart Association (AHA) have jointly issued a comprehensive set of data standards to help clarify definitions of the cardiovascular (CV) and non-CV complications of COVID-19. It's the work ...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://reference.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

A Scrotal Rash Lasting Months in a Man With Genital Edema
https://www.medscape.com/viewarticle/851819

Jun 23rd, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Diagnosis of PAH: What Are the Causes and Why Does It Take So Long?
https://www.medscape.com/viewarticle/968546

Jun 23rd, 2022 - This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello. I'm Dr Vallerie McLaughlin, the Kim A. Eagle Endowed Professor of Cardiovascular Medicine at the University of Michigan in Ann Arbor. I would like to welcome you to today...

ADA-EASD: More Holistic Approach Needed for Hyperglycemia Management
https://www.medscape.com/viewarticle/975212

Jun 23rd, 2022 - This transcript has been edited for clarity. In the 2022 Management of Hyperglycemia consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), the focus has shifted. Regarding t...

see more →

Patient Education  98 results see all →